Phair Pricing Act of 2019
Please tell your elected officials to cosponsor the "Phair Pricing Act of 2019" (H.R. 1034 / S. 640) and help end unpredictable retroactive pharmacy price concessions and help lower the cost of prescription medication for Medicare Part D patients.
U.S. Reps. Doug Collins (R-GA) and Vicente Gonzalez (D-TX) have introduced the Phair Pricing Act of 2019 (H.R. 1034), bipartisan legislation that would provide relief to community pharmacies and Medicare Part D beneficiaries by requiring all price concessions be included at the point of sale. Companion legislation (S.640) was introduced in the Senate by U.S. Sen. John Kennedy (R-LA). The legislation protects patients and provides greater oversight by accomplishing the following:
• Requires all price concessions between a pharmacy and PBM be included at the point of sale to decrease patient’s costs.
• Realigns market incentives to ensure patients have access to and receive the best possible care.
• Directs the Secretary of Health and Human Services to establish a working group of stakeholders to create quality measures based on a pharmacy’s practice.
• Ensures PBMs disclose all fees, price concessions, and programs to the Centers for Medicare & Medicaid Services (CMS).